Fatigue

Record number:

492

Adverse Occurrence type:

MPHO Type:

Estimated frequency:

Common

Alerting signals, symptoms, evidence of occurrence:

Fatigue. During days of injections

Demonstration of imputability or root cause:

Definite/probable. Temporal association with GCSF.

Keywords:

G-CSF (granulocyte colony-stimulating factor)

PBSC (peripheral blood stem cells)

References:

Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience

Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF?

Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program.

Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program

Peripheral blood stem cell mobilization and apheresis: analysis of adverse events in 94 normal donors

Mobilized blood cells vs bone marrow harvest: experience compared in 171 donors with particular reference to pain and fatigue

Stem cell mobilisation with 16 microg/kg vs 10 microg/kg of G-CSF for allogeneic transplantation in healthy donors

Efficacy and toxicity of a high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donors

Short and long-term safety of lenograstim administration in healthy peripheral haematopoietic progenitor cell donors: a single centre experience

Effects of granulocyte-colony-stimulating factor on potential normal granulocyte donors

Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells

Suggest references:

aaa